Pàgina inicial > Articles > Resultats de la cerca: Garcia, Xavier

Articles

  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Articles 67 registres trobats  anterior11 - 20següentfinal  anar al registre: La cerca s'ha fet en 0.00 segons. 
11.
34 p, 614.1 KB Rational development of bioprocess engineering strategies for recombinant protein production in Pichia pastoris (Komagataella phaffii) using the methanol-free GAP promoter. Where do we stand? / Garcia-Ortega, Xavier (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Cámara, Elena (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Ferrer, Pau (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Albiol i Sala, Joan (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Montesinos Seguí, José Luis (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Valero Barranco, Francisco (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental)
The increasing demand for recombinant proteins for a wide range of applications, from biopharmaceutical protein complexes to industrial enzymes, is leading to important growth in this market. Among the different efficient host organism alternatives commonly used for protein production, the yeast Pichia pastoris (Komagataella phaffii) is currently considered to be one of the most effective and versatile expression platforms. [...]
2019 - 10.1016/j.nbt.2019.06.002
New Biotechnology, Vol. 53 (November 2019) , p. 24-34  
Registre complet - Creative Commons
12.
17 p, 1.3 MB Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain : A retrospective analysis of electronic health records using Natural Language Processing / González-Juanatey, Carlos (Hospital Universitario Lucus Augusti (Lugo)) ; Anguita-Sánchez, Manuel (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Barrios, Vivencio (Hospital Universitario Ramón y Cajal (Madrid)) ; Núñez-Gil, Iván (Hospital Clínico San Carlos (Madrid)) ; Gómez-Doblas, Juan José (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Lafuente-Gormaz, Carlos (Complejo Hospitalario Universitario de Albacete) ; Rollán-Gómez, María Jesús (Hospital Universitario Río Hortega (Valladolid)) ; Peral-Disdie, Vicente (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martínez-Dolz, Luis (Hospital Universitari i Politècnic La Fe (València)) ; Rodríguez-Santamarta, Miguel (Hospital Universitario de León) ; Viñolas, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Soriano-Colomé, Toni (Hospital Universitari Vall d'Hebron) ; Muñoz-Aguilera, Roberto (Hospital Universitario Infanta Leonor) ; Plaza, Ignacio (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Curcio, Alejandro (Hospital Universitario de Fuenlabrada ( Madrid)) ; Orts-Soler, Ernesto (Consorci Hospitalari Provincial de Castelló) ; Segovia, Javier (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Maté, Claudia (Savana) ; Cequier, Ángel (Institut d'Investigació Biomèdica de Bellvitge)
Introduction and objectives Patients with type 2 diabetes (T2D) and stable coronary artery disease (CAD) previously revascularized with percutaneous coronary intervention (PCI) are at high risk of recurrent ischemic events. [...]
2022 - 10.1371/journal.pone.0263277
PloS one, Vol. 17 Núm. 2 February (february 2022) , p. e0263277  
Registre complet - Creative Commons
13.
9 p, 1.4 MB Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain / Gasch Blasi, Oriol (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Badia Cebada, Laia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Carmezim, João (Institut d'Investigació Biomèdica de Bellvitge) ; Vaqué, Montserrat (Hospital de Barcelona) ; Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ; Moreno, Encarna (Parc Sanitari Sant Joan de Déu) ; Marrón, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Jiménez Martínez, Emili (Hospital Universitari de Bellvitge) ; García Quesada, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia Alarcón, Xavier (Hospital Universitari de Girona Doctor Josep Trueta) ; Domènech, Dolors (Hospital Universitari de Girona Doctor Josep Trueta) ; Càmara, Jordi (Hospital Universitari de Bellvitge) ; Andrés, Marta (Consorci Sanitari de Terrassa. Hospital de Terrassa (Terrassa, Catalunya)) ; Peñafiel, Judith (Institut d'Investigació Biomèdica de Bellvitge) ; Porrón, Rosario (VINCat (Programa)) ; Limón, Enric (Universitat de Barcelona) ; Calbo Sebastián, Esther (Hospital Universitari Mútua Terrassa (Terrassa, Catalunya)) ; Pujol, Miquel (Hospital Universitari de Bellvitge) ; Universitat Autònoma de Barcelona
We compared hospital-acquired catheter-related bacteremia (CRB) episodes diagnosed at acute care hospitals in Catalonia, Spain, during the COVID-19 pandemic in 2020 with those detected during 2007-2019. [...]
2022 - 10.3201/eid2811.220547
Emerging Infectious Diseases, Vol. 28 Núm. 11 (november 2022) , p. 2181-2189  
Registre complet - Creative Commons
14.
12 p, 1.2 MB Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients : Identification of Associated Factors Using Electronic Health Records and Natural Language Processing / González-Juanatey, Carlos (Hospital Universitario Lucus Augusti (Lugo)) ; Anguita-Sánchez, Manuel (Instituto Maimónides de Investigación Biomédica de Córdoba) ; Barrios, Vivencio (Hospital Universitario Ramón y Cajal (Madrid)) ; Núñez-Gil, Iván (Hospital Clínico San Carlos (Madrid)) ; Gómez-Doblas, Juan José (Hospital Universitario Virgen de la Victoria. Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares. Instituto de Investigación Biomédica de Málaga) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Lafuente-Gormaz, Carlos (Complejo Hospitalario Universitario de Albacete) ; Rollán-Gómez, María Jesús (Hospital Universitario Río Hortega (Valladolid)) ; Peral-Disdier, Vicente (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Martínez-Dolz, Luis (Hospital Universitario y Politécnico La Fe. Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares. Instituto de Investigación Sanitaria La Fe de Valencia) ; Rodríguez-Santamarta, Miguel (Hospital Universitario de León) ; Viñolas, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Soriano-Colomé, Toni (Hospital Universitari Vall d'Hebron) ; Muñoz-Aguilera, Roberto (Hospital Universitario Infanta Leonor) ; Plaza, Ignacio (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Curcio, Alejandro (Hospital Universitario de Fuenlabrada ( Madrid)) ; Orts-Soler, Ernesto (Consorci Hospitalari Provincial de Castelló) ; Segovia, Javier (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Fanjul, Víctor (Savana Research) ; Cequier, Ángel (Institut d'Investigació Biomèdica de Bellvitge)
Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. [...]
2022 - 10.3390/jcm11206004
Journal of clinical medicine, Vol. 11 Núm. 20 (october 2022) , p. 6004  
Registre complet - Creative Commons
15.
14 p, 2.2 MB Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure / Diaz-Riera, Elisa (Institut d'Investigació Biomèdica Sant Pau) ; García-Arguinzonis, Maisa (Institut d'Investigació Biomèdica Sant Pau) ; López Vilaró, Laura (Institut d'Investigació Biomèdica Sant Pau) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Background: Renal function in acute decompensated heart faiulre (ADHF) is a strong predictor of disease evolution and poor outcome. Current biomarkers for early diagnostic of renal injury in the setting of ADHF are still controversial, and their association to early pathological changes needs to be established. [...]
2022 - 10.3389/fcvm.2022.829490
Frontiers in Cardiovascular Medicine, Vol. 9 (september 2022) , p. 829490  
Registre complet - Creative Commons
16.
19 p, 2.0 MB Urinary Proteomic Signature in Acute Decompensated Heart Failure : Advances into Molecular Pathophysiology / Diaz-Riera, Elisa (Institut d'Investigació Biomèdica Sant Pau) ; García-Arguinzonis, Maisa (Institut d'Investigació Biomèdica Sant Pau) ; López Vilaró, Laura (Institut d'Investigació Biomèdica Sant Pau) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Acute decompensated heart failure (ADHF) is a life-threatening clinical syndrome involving multi-organ function deterioration. ADHF results from multifaceted, dysregulated pathways that remain poorly understood. [...]
2022 - 10.3390/ijms23042344
International journal of molecular sciences, Vol. 23 Núm. 4 (February 2022) , p. 2344  
Registre complet - Creative Commons
17.
14 p, 423.1 KB Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice : The APALUSA Study / Vivencio, B. (Hospital Universitario Ramón y Cajal (Madrid)) ; Carlos, E. (Hospital Universitario La Paz (Madrid)) ; Carmen, S. (Hospital Universitario de la Princesa (Madrid)) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Francisco, L. (Vascular Surgery Department. University Hospital Clínico)
This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were included. [...]
2022 - 10.3390/jcm11123554
Journal of clinical medicine, Vol. 11 Núm. 12 (June 2022) , p. 3554  
Registre complet - Creative Commons
18.
16 p, 2.1 MB Recent therapeutic advances in urothelial carcinoma : A paradigm shift in disease management / Bellmunt, J. (Department of Medical Oncology. Beth Israel Deaconess Medical Center and IMIM-PSMAR Lab. Harvard Medical School) ; Valderrama, B.P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Puente, J. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Grande, Enrique (MD Anderson Cancer Center Madrid) ; Bolós, M.V. (Pfizer) ; Laínez, Nuria (Hospital Universitario de Navarra) ; Vázquez, S. (Hospital Universitario Lucus Augusti (Lugo)) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Climent, Miguel Ángel (Department of Medical Oncology. Valencia Institute of Oncology Foundation) ; Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ; Arranz, J.Á. (Hospital General Universitario Gregorio Marañón) ; Durán, Ignacio (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Universitat Autònoma de Barcelona
Management of first-line advanced urothelial carcinoma (UC) has consisted during the past three decades in the administration of platinum-based chemotherapy followed by observation. Despite moderate to high response rates to first-line treatment, most patients will relapse shortly after and the outcomes with subsequent therapies are poor with 5-year overall survival rates of 5% in the pre-immunotherapy era. [...]
2022 - 10.1016/j.critrevonc.2022.103683
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103683  
Registre complet - Creative Commons
19.
14 p, 2.6 MB Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts / Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Miah, Aisha B. (The Royal Marsden Hospital) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ; Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ; Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ; Antonescu, Cristina (Memorial Sloan Kettering Cancer Center) ; Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ; Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ; Bauer, Sebastian (University of Duisburg-Essen) ; Biagini, Roberto (Regina Elena National Cancer Institute) ; Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ; Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ; Boukovinas, Ioannis P. (Nordix) ; Bovee, Judith V.M.G. (Leiden University Medical Center) ; Boye, Kjetil (The Norwegian Radium Hospital) ; Brodowicz, Thomas (Medical University Vienna) ; Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ; Deoras-Sutliff, M. (The EHE Foundation) ; Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ; Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ; Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ; Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ; Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ; Garcia del Muro, Xavier (Universitat de Barcelona) ; Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ; Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ; Gouin, François (Department of Surgery. Centre Leon Berard) ; Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ; Gutkovich, J. (NUY Langone Medical Center) ; Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ; Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Hohenberger, Peter (Mannheim University Medical Center) ; Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ; Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ; Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ; Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ; Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ; Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ; Le Cesne, Axel (International Department. Gustave Roussy) ; Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ; Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ; Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ; Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ; Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Mir, Olivier (Sarcoma Group. Gustave Roussy) ; Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ; Montemurro, Michael (Oncology. CHUV Lausanne) ; Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ; Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ; Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ; Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ; Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ; Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ; Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ; Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ; Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ; Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ; Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ; Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ; Schöffski, Patrick (Leuven Cancer Institute) ; Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ; Strauss, Sandra J. (University College London Hospital) ; Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ; Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ; Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ; van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ; Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ; van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ; Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ; Wood, J. (The Royal Marsden NHS Foundation Trust) ; Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ; Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170  
Registre complet - Creative Commons
20.
28 p, 238.7 KB Asepsia, clínicas "particulares" y beneficencia pública : hacia un modelo asistencial dual en la ciudad de Valencia (1882-1936) / García Ferrandis, Xavier (Universidad Católica de Valencia)
Este trabajo se centra en el análisis de las primeras clínicas privadas de la ciudad de Valencia, una serie de pequeños hospitales quirúrgicos fundados a lo largo de las últimas décadas del siglo XIX y del primer tercio del XX en paralelo a un modelo de beneficencia insuficiente. [...]
This study focuses on the first private clinics in the city of Valencia, a series of small surgical hospitals established during the final decades of the 19th century and the first third of the next century in parallel with the weakness charity care model. [...]
2022 - 10.30827/dynamis.v42i1.26892
Dynamis : Acta Hispanica ad Medicinae Scientiarumque. Historiam Illustrandam, Vol. 42 Núm. 1 (2022) , p. 125-152 (Articles)  
Registre complet - Creative Commons

Articles : 67 registres trobats   anterior11 - 20següentfinal  anar al registre:
Vegeu també: autors amb noms similars
1 Garcia, Xavier Jariot
3 Garcia, Xenia
3 Garcia, Xènia
1 García, Xaime
5 García, Xavier
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem